By reducing estrogen production, Altraz helps limit the stimulation of cancer cells and supports long-term disease management under medical supervision.
Altraz 1 mg plays an important role in hormonal therapy for breast cancer, particularly for patients whose cancer is estrogen-dependent. By reducing estrogen levels, the medication may help slow the progression of the disease and improve treatment outcomes.
In addition to its clinical effects, proper treatment with medicines like Altraz may support long-term disease control, reduce the risk of cancer recurrence, and help patients maintain a better quality of life during treatment.
Effectiveness: Aromatase inhibitors such as anastrozole have been widely studied and are considered effective in treating hormone-receptor-positive breast cancer in postmenopausal women.
Onset Time: The medication begins lowering estrogen levels within a few hours after ingestion, though clinical benefits typically develop gradually with consistent use.
Duration of Action: Altraz works continuously when taken daily as prescribed, maintaining reduced estrogen levels in the body.
Cost Comparison: Generic anastrozole formulations, such as Altraz, are generally more affordable than some branded hormonal therapies while offering similar therapeutic effects.
Clinical Advantages: It may reduce the risk of breast cancer recurrence and is commonly used as part of long-term hormone therapy strategies.
Altraz 1 mg Tablet works through a hormone-blocking mechanism that targets estrogen production.
Altraz should be taken only as prescribed by a healthcare professional.
These are usually mild and may improve as the body adjusts to the medication.
Common Side Effects
Serious Side Effects